Ophthalmology, the future and beyond: opportunities and challenges for humanity
Technological triumphs and evidence-based caution: essential components on the ophthalmologic odyssey
Dr Eugene Michael and Angie Hu13 min read
Ophthalmology Comment
LETTER: ODOB on ‘blind trust’ claim
It was with interest that we at the Optometrists and Dispensing Opticians Board (ODOB) read Robert Ng’s Chalkeyes column, Blind trust in the ODOB?, in the May 2024 edition of NZ Optics. Ng refers to
Kristine Hammond, Suzanne Halpin5 min read
Anterior eye, smoking and glaucoma insights
Patterns in refractive error and treatment delay in keratoconus – an Australian study Bobba et al PloS one, 1932-6203,2024 Jan 11, Vol19. Issue 1 Review: This study provides valuable insights into
Dr Stefano Guglielmetti5 min read
Referral know how with Counties
Seeking to improve engagement and co-management of patients, Counties Manukau SuperClinic hosted an inaugural optometry open evening. Inspired by private practices’ CPD evenings, Counties optometris
Susanne Bradley5 min read
Calling all optometrists to Save Sight
Dr Oliver Comyn, chair of New Zealand’s Save Sight Society, is hoping more optometrists will join their ophthalmology and nursing colleagues at this year’s Save Sight Society meeting in Wellington.
Staff reporters2 min read
The power of workwear
Many workers in industries such as healthcare, trades and services, retail, hospitality and sales, require uniforms. But when it comes to workwear trends, there’s a growing emphasis on comfort and personal style. In hybrid environments, some adopt more casual clothing that reflects their individuali
Kumuda Setty3 min read
LETTER: Keratoconus management in NZ
LINK: https://nzoptics.co.nz/live-articles/current-state-of-keratoconus-management-in-new-zealand/
Dr Derek Sherwood2 min read
Cataract removal: No theatre? No problem!
A mobile air-sterilisation unit which allows cataract surgery to be performed in an office will help relieve some of the pressure on New Zealand’s hospitals, said supplier Medix21’s Camille Furnandiz.
Drew Jones2 min read
Blind trust in the ODOB?
ODOB's stance on the use of 'Dr' differs to that of the Dental Council, adding to a growing list of concerns about the board by some members of the optometry profession, opines Robert Ng.
Robert Ng5 min read
Orally delivered drugs in clinical trials for DR: looking into the future
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections, laser panretinal photocoagulation and intravitreal corticosteroid implants are clinically used to resolve diabetic macular oedema (DMO), the most common cause of vision loss in diabetic retinopathy (DR) patients.
Charisse Kuo, A/Prof Ilva Rupenthal, Prof Rinki Murphy and Dr Lola Mugisho9 min read
Vitreoretinal research review - May 2024
Real-world safety and effectiveness of voretigene neparvovec: results up to two years from the prospective, registry-based Perceive study Fischer M, et al Biomolecules. 2024 Jan 17;14(1):122. Review
Dr Oliver Comyn6 min read
Who CAIRS? ANZCS does!
A scorching midweek ANZCS meeting took place at the stunning Sheraton Hotel with a two-day programme packed with innovation, discussion and expertise.
Dr Natalie Allen6 min read